Izzard Aglua

Izzard Aglua

Auto-generated profile, based on publicly available information

Izzard Aglua

Sir Joseph Nombri Memorial-Kundiawa General Hospital, Kundiawa, 461, Simbu Province, Papua New Guinea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ESEike Steinig
Eike Steinig
IAIzzard Aglua
Izzard Aglua
SDSebastián Duchêne
Sebastián Duchêne
MMMichael T. Meehan
Michael T. Meehan
MYMition Yoannes
Mition Yoannes
EMEmma McBryde
Emma McBryde
Community-associated, methicillin-resistant Staphylococcus aureus (MRSA) lineages have emerged in many geographically distinct regions around the world during the past 30 y. Here, we apply consistent phylodynamic methods across multiple community-associated MRSA lineages to describe and contrast their patterns of emergence and dissemination. We generated whole-genome sequencing data for the Australian sequence type (ST) ST93-MRSA-IV from remote communities in Far North Queensland and Papua New Guinea, and the Bengal Bay ST772-MRSA-V clone from metropolitan communities in Pakistan. Increases in the effective reproduction number (R e ) and sustained transmission (R e > 1) coincided with spread of progenitor methicillin-susceptible S. aureus (MSSA) in remote northern Australian populations, dissemination of the ST93-MRSA-IV genotype into population centers on the Australian East Coast, and subsequent importation into the highlands of Papua New Guinea and Far North Queensland. Applying the same phylodynamic methods to existing lineage datasets, we identified common signatures of epidemic growth in the emergence and epidemiological trajectory of community-associated S. aureus lineages from America, Asia, Australasia, and Europe. Surges in R e were observed at the divergence of antibiotic-resistant strains, coinciding with their establishment in regional population centers. Epidemic growth was also observed among drug-resistant MSSA clades in Africa and northern Australia. Our data suggest that the emergence of community-associated MRSA in the late 20th century was driven by a combination of antibiotic-resistant genotypes and host epidemiology, leading to abrupt changes in lineage-wide transmission dynamics and sustained transmission in regional population centers.

1 October 2018
Verified
Closed access
PDF file
IAIzzard Aglua
Izzard Aglua
JJJan Jaworski
Jan Jaworski
JDJimmy Drekore
Jimmy Drekore
BUBohu Urakoko
Bohu Urakoko
HPHarry Poka
Harry Poka
AGAndrew Greenhill
Andrew Greenhill

4 September 2022 in medRxiv
Verified
Preprint
Open access
PDF file
SAStanley Aiwara
Stanley Aiwara
IAIzzard Aglua
Izzard Aglua
IKIsi H. Kevau
Isi H. Kevau
DLDavid Linge
David Linge
Background: Tuberculous meningitis is the most severe form of extrapulmonary TB and accounted for 5% of 10 million global TB cases in the WHO 2018 report, with mortality as high as 19% in children and 30% in adults. Clinicians in resource-poor settings are often challenged by limited diagnostic and therapeutic options for optimal patient care, and often rely on clinical parameters for diagnosis, treatment, monitoring and outcome. Aim: This study was done to identify potential clinical predictors of i) 28-day mortality and ii) length of hospitalization, amongst Melanesian adults with TB meningitis at a provincial hospital in Papua New Guinea. Method: A retrospective observational study was conducted on 65 Melanesian adults with TB meningitis at a provincial hospital in Papua New Guinea between 2015 and 2019. Result: High case fatality (49%) and mortality rates (2.22 per 100 000 per year) for TB Meningitis were observed in this study. Even higher case fatality of 93% observed for HIV-TBM co-infection. 28-day mortality associated with HIV-TBM co-infection (p-value=0.007, 95% CI 2.49-289.19), positive fluid balance 24-hours after admission (p-value=0.019, 95% CI 1.23-10.19) and admission GCS ≤10 (p-value=0.049, 95% CI 1.01-16.58). Conclusion: Study showed high case fatality (49%) and mortality rates (2.22 per 100,000 per year) for TB Meningitis in Melanesian adults, with significantly high case fatality (93%) for HIV-TBM co-infection. HIV-TBM co-infection was strongly associated with 28-day mortality whilst a positive fluid balance 24-hours after admission and admission-GCS ≤10 were weakly associated with 28-day mortality.

21 May 2021 in medRxiv
Verified
Preprint
Open access
PDF file
IBIan Billy
Ian Billy
IAIzzard Aglua
Izzard Aglua
Background: Evidence suggest a potential relationship between high or variable HbA 1 C levels and presence or rate of change of microalbuminuria. Disruption of the vascular endothelial glycocalyx has been linked to chronic hyperglycemia and microalbuminuria, suggesting a possible shared pathophysiological mechanism. Aim: To 1) explore potential association between microalbuminuria and high HbA 1 C levels in Melanesian adults with diabetes mellitus, and 2) asses predictive value of a high HbA 1 C reading as an indicator of the presence or progression of microalbuminuria. Method: A cross-sectional study on 190 patients with either type 1 or 2 diabetes of at least 1-year duration done at a provincial hospital in Papua New Guinea in 2017. Result: A significant [P=0.0221], though weak [R 2 =0.028 <0.70], correlation between UACR and HbA 1 C [95% statistical confidence] was observed in univariate regression, which was marginally significant [P=0.056] after controlling for weight, systolic hypertension, duration of diabetes, gender and age in multivariate regression. Conclusion: A significant [p=0.022], though weak, correlation between UACR and HbA 1 C levels was observed, which may support usefulness of HbA 1 C as a predictor for microalbuminuria and diabetic kidney disease. In settings without microalbuminuria testing, high HbA1c levels can be used as a proxy to indicate presence or progression of microalbuminuria, thus prompting timely interventions to prevent further progression of diabetic nephropathy.